BR112015001892A2 - cocleados feitos com fosfatidilserina de soja - Google Patents

cocleados feitos com fosfatidilserina de soja

Info

Publication number
BR112015001892A2
BR112015001892A2 BR112015001892A BR112015001892A BR112015001892A2 BR 112015001892 A2 BR112015001892 A2 BR 112015001892A2 BR 112015001892 A BR112015001892 A BR 112015001892A BR 112015001892 A BR112015001892 A BR 112015001892A BR 112015001892 A2 BR112015001892 A2 BR 112015001892A2
Authority
BR
Brazil
Prior art keywords
phosphatidylserine
cochleates
soybean phosphatidylserine
soybean
soy
Prior art date
Application number
BR112015001892A
Other languages
English (en)
Other versions
BR112015001892A8 (pt
BR112015001892B1 (pt
Inventor
Mannino Raphael
Lu Ruying
Original Assignee
Coordinated Program Dev Llc
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coordinated Program Dev Llc, Univ Rutgers filed Critical Coordinated Program Dev Llc
Publication of BR112015001892A2 publication Critical patent/BR112015001892A2/pt
Publication of BR112015001892A8 publication Critical patent/BR112015001892A8/pt
Publication of BR112015001892B1 publication Critical patent/BR112015001892B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo patente de invenção: "cocleados feitos com fosfatidilserina de soja". a presente invenção refere-se à fosfatidilserina soja pura não purificada ou inferior que é usada para fazer cocleados. os cocleados contêm cerca de 40-74% de fosfatidilserina de soja, um cátion multivalente e um ativo biológico. um cocleado preferido contém o agente antifúngico anfotericina b.
BR112015001892-0A 2012-07-30 2013-07-30 cocleados feitos com fosfatidilserina de soja e método para a produção de cocleados de fosfatidilserina de soja/ativo biológico BR112015001892B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261677414P 2012-07-30 2012-07-30
US61/677,414 2012-07-30
US201361835825P 2013-06-17 2013-06-17
US61/835,825 2013-06-17
PCT/US2013/052756 WO2014022414A1 (en) 2012-07-30 2013-07-30 Cochleates made with soy phosphatidylserine

Publications (3)

Publication Number Publication Date
BR112015001892A2 true BR112015001892A2 (pt) 2017-07-04
BR112015001892A8 BR112015001892A8 (pt) 2017-10-10
BR112015001892B1 BR112015001892B1 (pt) 2021-02-02

Family

ID=50028476

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001892-0A BR112015001892B1 (pt) 2012-07-30 2013-07-30 cocleados feitos com fosfatidilserina de soja e método para a produção de cocleados de fosfatidilserina de soja/ativo biológico

Country Status (14)

Country Link
US (5) US20150297725A1 (pt)
EP (2) EP2879502B1 (pt)
JP (2) JP6444865B2 (pt)
KR (1) KR102115718B1 (pt)
CN (1) CN105050409B (pt)
AU (1) AU2013296651B2 (pt)
BR (1) BR112015001892B1 (pt)
CA (1) CA2879931C (pt)
DK (1) DK2879502T3 (pt)
ES (1) ES2688397T3 (pt)
HK (1) HK1211181A1 (pt)
MX (1) MX361155B (pt)
RU (1) RU2659729C2 (pt)
WO (1) WO2014022414A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022414A1 (en) 2012-07-30 2014-02-06 Coordinated Program Development, Llc Cochleates made with soy phosphatidylserine
JP6770524B2 (ja) * 2015-03-03 2020-10-14 マティナス バイオファーマ ナノテクノロジーズ，インコーポレーテッド コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法
CA2982259A1 (en) * 2015-04-22 2016-10-27 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating mycobacteria infections and lung disease
CN107920991A (zh) * 2015-06-18 2018-04-17 马丁尼斯生物制药纳米技术公司 治疗炎性疾病或病状的组合物和方法
CN108366974A (zh) * 2015-12-16 2018-08-03 维韦克·阿南德·帕拉库尔 天然化合物的三分子复合物
AU2017297402B2 (en) 2016-07-12 2023-02-09 Matinas Biopharma Nanotechnologies, Inc. Encochleated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
US20190083518A1 (en) * 2017-09-20 2019-03-21 Atopic Medical, LLC Compositions and methods for treating and ameliorating respiratory conditions and inflammation of mucosa
KR101989789B1 (ko) * 2017-11-30 2019-06-18 (주) 에이치엔에이파마켐 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트
ES1245259Y (es) 2019-05-10 2020-08-24 Bionova Slu Emulsiones de los cannabinoides del aceite de cáñamo
CA3208643A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof
WO2023183297A1 (en) * 2022-03-21 2023-09-28 The Board Of Trustees Of The University Of Illinois Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin b
WO2024039733A1 (en) 2022-08-16 2024-02-22 Matinas Biopharma Nanotechnologies, Inc. Methods of controlling lipid nanocrystal particle size and lipid nanocrystals produced by such methods
WO2024039729A1 (en) 2022-08-16 2024-02-22 Matinas Biopharma Nanotechnologies, Inc. Antifungal agent encapsulated in a lipid nanocrystal for treating mucormycosis

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JPH0550062A (ja) 1991-05-29 1993-03-02 Toray Ind Inc 水溶液の浄化法
AU3246093A (en) * 1991-12-11 1993-07-19 Temple University - Of The Commonwealth System Of Higher Education Amphotericin B composition with enhanced antifungal activity
AU3244393A (en) * 1992-12-02 1994-06-22 Vestar, Inc. Antibiotic formulation and process
US6663885B1 (en) * 1993-03-15 2003-12-16 A. Natterman & Cie Gmbh Aqueous liposome system and a method for the preparation of such a liposome system
US5554382A (en) * 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
AU4981896A (en) * 1995-02-14 1996-09-04 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering liposome-loadable drugs
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
WO2002085337A1 (en) 2001-04-20 2002-10-31 The University Of British Columbia Micellar drug delivery systems for hydrophobic drugs
JP3697189B2 (ja) 2001-01-11 2005-09-21 日清オイリオグループ株式会社 リン脂質の塩基交換方法
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
US20030219473A1 (en) * 2002-03-26 2003-11-27 Leila Zarif Cochleates made with purified soy phosphatidylserine
DE10228680A1 (de) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Grundlage für transdermale Formulierungen (PTF)
CN1674869A (zh) 2002-08-06 2005-09-28 金拓 非金属阳离子作桥联剂的脂质卷
WO2004037271A1 (en) * 2002-10-25 2004-05-06 Vasogen Ireland Limited Cyclooxygenase regulation with ps liposomes
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
JP4886297B2 (ja) * 2002-11-01 2012-02-29 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド ジオデート送達媒体
WO2004064805A1 (en) * 2003-01-15 2004-08-05 Biodelivery Sciences International, Inc. Cochleate preparations of fragile nutrients
WO2004091572A2 (en) * 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Cochleate compositions directed against expression of proteins
EP1624858B1 (en) 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Novel encochleation methods
JP4891522B2 (ja) * 2003-10-03 2012-03-07 株式会社ファンケル 血清ｇｏｔ、ｇｐｔ改善剤
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2010091090A1 (en) * 2009-02-03 2010-08-12 Biodelivery Sciences International, Inc. Cochleate compositions and methods of use
JP5621204B2 (ja) * 2009-03-31 2014-11-12 日油株式会社 血管老化予防剤
US20100239521A1 (en) * 2010-06-01 2010-09-23 Mohammad Reza Mozafari Method for the preparation of micro- and nano-sized carrier systems for the encapsulation of bioactive substances
EP2689775A1 (en) * 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
WO2014022414A1 (en) * 2012-07-30 2014-02-06 Coordinated Program Development, Llc Cochleates made with soy phosphatidylserine

Also Published As

Publication number Publication date
EP2879502B1 (en) 2018-09-05
CN105050409A (zh) 2015-11-11
KR102115718B1 (ko) 2020-05-28
AU2013296651B2 (en) 2017-03-02
MX2015001348A (es) 2016-03-04
EP2879502A1 (en) 2015-06-10
US20150297725A1 (en) 2015-10-22
JP6751424B2 (ja) 2020-09-02
JP6444865B2 (ja) 2018-12-26
ES2688397T3 (es) 2018-11-02
EP2879502A4 (en) 2016-03-09
JP2015528021A (ja) 2015-09-24
RU2015105881A (ru) 2016-09-20
KR20150107707A (ko) 2015-09-23
DK2879502T3 (en) 2018-10-15
WO2014022414A1 (en) 2014-02-06
US10716860B2 (en) 2020-07-21
US9775907B2 (en) 2017-10-03
RU2659729C2 (ru) 2018-07-03
US11964019B2 (en) 2024-04-23
CA2879931C (en) 2020-12-15
US20180185491A1 (en) 2018-07-05
AU2013296651A1 (en) 2015-03-19
US20150147380A1 (en) 2015-05-28
EP3461338A1 (en) 2019-04-03
BR112015001892A8 (pt) 2017-10-10
CA2879931A1 (en) 2014-02-06
CN105050409B (zh) 2018-05-25
US9370572B2 (en) 2016-06-21
HK1211181A1 (en) 2016-05-20
US20210038722A1 (en) 2021-02-11
BR112015001892B1 (pt) 2021-02-02
US20150140074A1 (en) 2015-05-21
MX361155B (es) 2018-11-28
JP2018203750A (ja) 2018-12-27

Similar Documents

Publication Publication Date Title
BR112015001892A2 (pt) cocleados feitos com fosfatidilserina de soja
BR112014027165A2 (pt) antagonistas de st2l e métodos de uso
DOP2013000300A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
BR102012013921A2 (pt) instrumento cirérgico
ECSP11010905A (es) Uso de ditiina-tetracarboximidas para combatir hongos fitopatógenos
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
BR112018000632A2 (pt) moléculas de anticorpo que ligam a cd79
BR112014015851A2 (pt) proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
BRPI0815008B8 (pt) vacinas multiméricas com múltiplos epítopos contra influenza
CR20150315A (es) Biocontrol de nemátodos fitoparásitos mediante paecilomyces
BR112016013109A2 (pt) anticorpos de anti-siglec-8 e métodos de seu uso
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
BRPI0916069B8 (pt) composto, usos de um composto e composição farmacêutica
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
BR112015005789A2 (pt) Formulações que compreende idebenona, n-acetil- s-farnesil-l-cisteína e ergotioneína e usos das mesmas
BR112016013343A2 (pt) Composições de emulsão e aplicações para as mesmas
CL2013000310A1 (es) Compuestos derivados de tetrahidrofuranilo disustituidos y sus sales, como antagonistas del receptor b1 de bradiquinina; medicamento que contiene a dichos compuestos; su procedimiento de preparacion, util para el tratamiento agudo o profilactico de dolores agudos, osteoartritis, asma, alergias, entre otras enfermedades.
BR112014016942A2 (pt) cunha dental
BR112015020222A8 (pt) composto de azetidiniloxifenilpirrolidina, seus usos, e composições farmacêuticas
UY29417A1 (es) Agentes endoparasiticidas
BR112016002317A8 (pt) Uso de benralizumab ou de um seu fragmento de ligação ao antígeno para aumentar o volume expiratório forçado em asmáticos e benralizumab ou de um seu fragmento de ligação ao antígeno para uso para aumentar o volume expiratório forçado em asmáticos
WO2014140911A3 (en) Diagnostic and therapeutic methods relating to microrna-144
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
BR112015013725A2 (pt) cepa de levedura

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) ,

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A21D 2/00

Ipc: A61K 9/127 (2006.01), A61K 47/24 (2006.01)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/07/2013, OBSERVADAS AS CONDICOES LEGAIS.